Coghlan John G, Rothman Alexander Mk, Hoole Stephen P
Royal Free Hospital London, UK.
Sheffield Teaching Hospitals NHS Trust Sheffield, UK.
Interv Cardiol. 2021 Feb 15;16:e02. doi: 10.15420/icr.2020.14. eCollection 2020 Apr.
Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic thromboembolic pulmonary hypertension. While cardiologists need no introduction to the concept of balloon angioplasty, BPA has its own particular challenges. This article aims to provide the reader with an overview of BPA, starting with an introduction to chronic thromboembolic disease (CTED), the standard management of chronic thromboembolic pulmonary hypertension (CTEPH), technical challenges faced when performing BPA and the evidence base supporting its use. The second part of the article will focus on the future of BPA, in particular the areas where research is required to establish an evidence base to justify the role of BPA in CTEPH and CTED treatment.
球囊肺动脉血管成形术(BPA)是一种治疗慢性血栓栓塞性肺动脉高压的新技术。虽然心脏病专家对球囊血管成形术的概念无需介绍,但BPA有其自身独特的挑战。本文旨在为读者提供BPA的概述,首先介绍慢性血栓栓塞性疾病(CTED)、慢性血栓栓塞性肺动脉高压(CTEPH)的标准治疗、进行BPA时面临的技术挑战以及支持其应用的证据基础。本文的第二部分将聚焦于BPA的未来,特别是需要开展研究以建立证据基础来证明BPA在CTEPH和CTED治疗中的作用的领域。